The present invention relates to novel 3-hetero-arylidene-2-indolinone
compounds and physiologically acceptable salts thereof which modulate the
activity of protein kinases and therefore are expected to be useful in
the prevention and treatment of protein kinase related cellular disorders
such as cancer.